ERK 1 Inhibitors

The activation of signal transduction pathways by growth factors, hormones and neurotransmitters is mediated through two closely related MAP kinases, p44 and p42, designated extracellular-signal related kinase 1 (ERK 1) and ERK 2, respectively. Biochemicals that inhibit ERK 1 have many applications in biochemical and physiological research. Click on the product name to view detailed information such as the chemical structure and specific chemical properties for each of our ERK 1 Inhibitors. In stock ERK 1 Inhibitors are available for immediate shipping.

indicates a highly recommended product based on customer preference.

PRODUCT NAME/Application CAS Catalog # QUANTITY Price Citations RATING
Evodiamine
An antiangiogenic and antiinflammatory agonist of TRPV1
518-17-2 sc-201479
sc-201479A
20 mg
100 mg
$20.00
$70.00
3
ERK Inhibitor II, FR180204
A novel ERK-selective inhibitor
865362-74-9 sc-203945
1 mg
$100.00
21
p38 MAP Kinase Inhibitor IV
An ATP-competitive p38α/β MAPK inhibitor
1638-41-1 sc-204159
10 mg
$169.00
0
SC1 (Pluripotin)
A sustainer of mES self-renewal and ERK 1 inhibitor
839707-37-8 sc-255607
1 mg
$156.00
0
Olomoucine
A potent and selective inhibitor of Cdc2 and ERK1
101622-51-9 sc-3509
sc-3509A
5 mg
25 mg
$72.00
$274.00
9
SCH772984
A novel and selective inhibitor of ERK1/2 that displays behaviors of both type I and type II kinase inhibitors and has nanomolar cellular potency in tumor cells
942183-80-4 sc-473205
5 mg
$350.00
1

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.